For Research Purposes Only — This compound is not FDA approved.

Catalog
KLOW
Tissue Repair Research

KLOW

A multi-peptide research blend studied for tissue-repair and regenerative signaling in research models. Premium Research Peptide.

Amount
Quantity
1
Bundle & Save
COA
Only 42 left in stock 18 people viewing now
Est. delivery in 2–5 business days
Free shipment protection
Overnight shipping available

Certificate of Analysis

Third Party Tested Freedom Diagnostics
99.80%
Purity · HPLC-UV
Latest BatchLC-MS IdentityUS Tested
Passed QC panel
Lot KL80-001Tested Jun 22, 2026
Purity (HPLC-UV)99.80%
Net Peptide Content94.16mg
Identity (LC-MS)GHK-Cu / KPV / TB-500 / BPC-157
Freedom Diagnostics · Independent third-party lab View full COA

Compound Information

Technical specifications
Molecular Profile

What is KLOW?

TypePeptide blend
CAS NumberBlend — see composition
Molecular WeightBlend — see composition
Amino AcidsBlend — see composition
CompositionGHK-Cu 50mg · BPC-157 10mg · TB-500 10mg · KPV 10mg
PubChem Database KLOW Blend Research Guide
Storage Requirements

Stability Information

Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
−20°C · 24+ months
Reconstituted
2–8°C · ~30 days

Research Background

For laboratory research use only

What the KLOW blend contains

KLOW is a four-component blend lyophilised in one vial: GHK-Cu, BPC-157, TB-500 and KPV, in the amounts given on the specification card above. It is the three-component GLOW blend with KPV added. Like GLOW, the name is a trade designation from the research-supply market and does not appear in the scientific literature as a defined entity.

The four components fall into two size classes. GHK-Cu and KPV are tripeptides, the first a copper(II) complex of glycyl-histidyl-lysine and the second the lysine-proline-valine fragment from the C-terminus of alpha-MSH. BPC-157, with 15 amino acids, and TB-500 (thymosin beta-4), with 43, are conventional synthetic peptides. That split matters more for analysis and handling than it might seem.

What the preclinical literature has examined

  • KPV. NF-kB signalling in cultured epithelial and immune cells, uptake by the PepT1 transporter, and murine models of intestinal inflammation.
  • GHK-Cu. Collagen and glycosaminoglycan synthesis in fibroblast cultures, metalloproteinase regulation and gene-expression profiling.
  • BPC-157. Rodent models of tendon, muscle and gastrointestinal injury.
  • Thymosin beta-4. Actin sequestration, cell migration and angiogenesis assays.
  • The four together. No meaningful published literature exists on this combination. The rationale usually offered, that one component addresses inflammatory signalling while the others address matrix and cell migration, is an inference from four separate bodies of single-compound work, not a tested result.

For that reason an experiment using the blend needs single-compound controls before any observation can be attributed to a component. None of the four is an approved drug; this material is supplied for in vitro and laboratory research only and is not for human, veterinary or cosmetic use. See the KLOW blend research guide, and the KPV and GHK-Cu guides for the two tripeptides.

How a four-component blend is characterised

Four components mean four identities to confirm. On reversed-phase HPLC the two larger peptides are well retained and easy to separate, but the two tripeptides are both small and hydrophilic and elute early, close to each other and to the solvent front. Resolving them takes a method designed for the purpose, and it is the reason mass spectrometry carries so much weight for this product: LC-MS identity must account for all four molecular masses, and a result that confirms three leaves the fourth unverified. Net peptide content gives the measured peptide mass in the vial. The Certificate of Analysis above reports these results for the lot. See HPLC vs mass spectrometry and how to read a Certificate of Analysis.

Handling in the laboratory

KPV itself is robust, so adding it does not add a new chemical vulnerability; the blend is governed by the same two components as GLOW. GHK-Cu loses its copper to chelators such as EDTA, to strongly acidic buffers and to reducing agents. Thymosin beta-4 has a methionine that oxidises on exposure to air and light. What KPV does add is hygroscopic mass: with two tripeptides in the vial, the powder takes up water readily, so let the vial reach room temperature before opening and reseal promptly. The blend is blue because of the copper complex. Keep the powder frozen and dry, reconstitute by gentle swirling, and store solutions cold in single-use aliquots. See peptide storage and stability and how to reconstitute a research peptide.

Common questions

What is the difference between KLOW and GLOW?

KLOW contains the same three components as GLOW, which are GHK-Cu, BPC-157 and TB-500, plus a fourth, the tripeptide KPV. The amount of each is listed in the composition line of the specification card.

What is in the KLOW blend?

Four components lyophilised together: GHK-Cu, BPC-157, TB-500 (thymosin beta-4) and KPV. Two are tripeptides and two are larger synthetic peptides of 15 and 43 amino acids.

Is there published research on the four peptides together?

No meaningful body of work exists on the four-way combination. Each component has its own preclinical literature, so experiments with the blend need single-compound controls to attribute an effect to one component.

Is the KLOW blend approved for human use?

No. None of the four components is an approved drug. This material is sold for in vitro and laboratory research only and is not for human, veterinary or cosmetic use.

How is a four-peptide blend verified?

LC-MS should find the molecular mass of each of the four components, and HPLC should resolve them, which is harder for the two small tripeptides. Net peptide content gives the measured peptide mass in the vial. Results are on the Certificate of Analysis for the lot.

Frequently Researched Together

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing, you confirm that you are a qualified researcher and will use these products in accordance with all applicable laws and regulations.